BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17609196)

  • 1. Improved survival in HIV-infected persons: consequences and perspectives.
    Lohse N; Hansen AB; Gerstoft J; Obel N
    J Antimicrob Chemother; 2007 Sep; 60(3):461-3. PubMed ID: 17609196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The road to success. Long-term prognosis for persons living with HIV in Denmark - time trends and risk factors.
    Lohse N
    Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America.
    Aberg JA; Kaplan JE; Libman H; Emmanuel P; Anderson JR; Stone VE; Oleske JM; Currier JS; Gallant JE;
    Clin Infect Dis; 2009 Sep; 49(5):651-81. PubMed ID: 19640227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
    Patel K; HernĂ¡n MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
    Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment at scale in Brazil: a physician's perspective.
    Schechter M
    AIDS; 2007 Jul; 21 Suppl 4():S31-5. PubMed ID: 17620750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The chronicity of HIV infection].
    Morlat P
    Rev Prat; 1999 Oct; 49(16):1781-5. PubMed ID: 10578609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvements in antiretroviral therapy outcomes over calendar time.
    Boyd MA
    Curr Opin HIV AIDS; 2009 May; 4(3):194-9. PubMed ID: 19532050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation.
    Szczech LA
    Curr Opin HIV AIDS; 2009 May; 4(3):167-70. PubMed ID: 19532045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The current and future situations of TB/HIV (co-infection of tuberculosis and HIV) in Japan].
    Yamada N; Nagai H
    Kekkaku; 2009 Apr; 84(4):203-11. PubMed ID: 19425395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prioritizing primary care in HIV: comorbidity, toxicity, and demography.
    Justice AC
    Top HIV Med; 2006 Dec-2007 Jan; 14(5):159-63. PubMed ID: 17237557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
    Palombi L; Marazzi MC; Voetberg A; Magid NA
    AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The study to understand the natural history of HIV and AIDS in the era of effective therapy (SUN Study).
    Vellozzi C; Brooks JT; Bush TJ; Conley LJ; Henry K; Carpenter CC; Overton ET; Hammer J; Wood K; Holmberg SD;
    Am J Epidemiol; 2009 Mar; 169(5):642-52. PubMed ID: 19074775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-resistant human immunodefiency virus.
    Kozal MJ
    Clin Microbiol Infect; 2009 Jan; 15 Suppl 1():69-73. PubMed ID: 19220361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New challenges in therapeutic management of human immunodeficiency virus-infected children].
    Faye A
    Arch Pediatr; 2007 Feb; 14(2):212-8. PubMed ID: 17222540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Withdrawal symptoms as a predictor of mortality in patients HIV-infected through drug use and receiving highly active antiretroviral therapy (HAART).
    Michel L; Giorgi R; Villes V; Poizot-Martin I; Dellamonica P; Spire B; Protopopescu C; Carrieri MP
    Drug Alcohol Depend; 2009 Jan; 99(1-3):96-104. PubMed ID: 18774237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents: the recommendations of the Thai AIDS Society (TAS) 2008.
    Sungkanuparph S; Anekthananon T; Hiransuthikul N; Bowonwatanuwong C; Supparatpinyo K; Mootsikapun P; Chetchotisakd P; Kiertiburanakul S; Tansuphaswadikul S; Buppanharun W; Manosuthi W; Techasathit W; Ratanasuwan W; Tantisiriwat W; Suwanagool S; Leechawengwongs M; Ruxrungtham K;
    J Med Assoc Thai; 2008 Dec; 91(12):1925-35. PubMed ID: 19133532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antiretroviral therapy in critically ill patients: a French national study].
    Dinh A; Salomon J; Vuagnat A; De Truchis P; Maury E; Bernard L
    Med Mal Infect; 2007 Dec; 37(12):809-15. PubMed ID: 17628372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of human immunodeficiency virus-infected and -exposed children undergoing surgery--a prospective study.
    Karpelowsky JS; Leva E; Kelley B; Numanoglu A; Rode H; Millar AJ
    J Pediatr Surg; 2009 Apr; 44(4):681-7. PubMed ID: 19361626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Life expectancy living with HIV: recent estimates and future implications.
    Nakagawa F; May M; Phillips A
    Curr Opin Infect Dis; 2013 Feb; 26(1):17-25. PubMed ID: 23221765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.